02320cam a2200517Ma 4500 ocn816811904 OCoLC 20171113083425.0 m o d cr |n||||||||| 120813s2012 enk fob 001 0 eng d 9781118407738 (electronic bk.) 1118407733 (electronic bk.) 9781118407783 (electronic bk.) 1118407784 (electronic bk.) 0470949457 9780470949450 9781283593267 1283593262 NZ1 15900836 DEBBG BV043395179 (OCoLC)816811904 (OCoLC)810317483 (OCoLC)817811911 390571 MIL CDX eng pn CDX OCLCO IDEBK MHW OCLCQ DG1 OCLCQ OCLCF OCLCQ UIU OCLCQ DEBBG MAIN RS420 HEA eflch 615.1/9 23 Bodor, Nicholas. Retrometabolic drug design and targeting / Nicholas Bodor, Peter Buchwald. [electronic resource] Oxford : Wiley-Blackwell, 2012. 1 online resource (438 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references and index. This book provides researchers in drug discovery and design with complete guidance on how to use retrometabolic approaches to develop safe, effective, and targeted drug therapies. Written by pioneers in soft drugs and retrometabolics, the book brings together for the first time a wealth of information from across the literature, offering a single source of valuable ideas, methods, and references to the problems of drug design, optimization, stability, side effects, and toxicity. Authoritative coverage includes both important fundamentals and practical examples illustrating applications in drug design. Print version record. Drugs Design. Drugs Design. fast (OCoLC)fst00898790 Electronic books. Buchwald, Peter. Print version: 9781283593267 http://onlinelibrary.wiley.com/book/10.1002/9781118407738 Wiley Online Library ddc BK 206252 206252